Form 4: Agilon Health CEO Steven Sell Reports Stock Disposals to Cover Tax Obligations and Trust Transfer

Agilon Health's CEO, Steven Sell, reported disposing of shares to cover tax obligations related to restricted stock units and a transfer of shares into a trust.

Summary

• On April 14, 2025, Steven Sell, CEO and President of Agilon Health, disposed of 7,898 shares of common stock at a price of $5.6 to cover income tax withholding.
• Following this transaction, Sell directly owns 884,685 shares.
• Also on April 14, 2025, 14,198 shares were transferred into a trust, changing the ownership from direct to indirect.
• On April 15, 2025, Sell disposed of 22,563 shares of common stock at a price of $5.53 to cover income tax withholding.
• Following this transaction, Sell directly owns 862,122 shares.
• Sell also indirectly owns 81,788 shares through a revocable trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports routine stock disposals for tax purposes and a transfer to a trust, without indicating any significant positive or negative implications for the company.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership structure, but the disposals are primarily for tax obligations and trust transfer.

Key Dates

Keywords

Agilon Health, Steven Sell, stock disposal, Form 4, insider trading, trust transfer, tax withholding, AGL